MSL Captive Solutions, the leading managing general underwriter dedicated to captive programs for medical stop loss, today announced that it has been acquired by MedImpact, the nation’s largest independent health solutions and pharmacy benefit company.
Through this strategic alignment, MSL Captive Solutions will gain access to MedImpact’s scale, resources, and deep clinical expertise, enabling MSL to help clients more effectively control healthcare costs by addressing the clinical drivers of catastrophic claims.
MSL’s medical stop-loss and underwriting expertise will now be bolstered by a broader portfolio of care and coverage solutions, including:
• Advanced Clinical Programs: High-touch specialty drug management and member care.
• Predictable Risk Management: Innovative alternatives to inflexible, traditional insurance programs.
• Total Control: Modular solutions that put power back into the hands of employers.
“As a part of the MedImpact family of companies, we will deliver to health plans even greater predictability and control over their healthcare costs,” said Andrew Berry, MSL Captive Solutions President. “This has never been more important than it is today, and we’re thrilled to make this announcement.”
The acquisition expands MedImpact’s growing portfolio of health solutions, which includes third-party administration, provider networks, and drug savings programs. For MSL clients, this means a more robust ecosystem designed to distance employers from market volatility.
“Small and mid-sized businesses today struggle to manage runaway healthcare costs with the inflexible and opaque traditional insurance programs,” said Zach Johnson, MedImpact Executive Vice President. “We are putting power back in the hands of employers by giving them innovative alternatives, transparency, flexibility, and total control.”